InvestorsHub Logo
Followers 85
Posts 7299
Boards Moderated 1
Alias Born 12/03/2002

Re: None

Saturday, 05/17/2014 2:18:42 PM

Saturday, May 17, 2014 2:18:42 PM

Post# of 54143
IMPORTANT NEW DOCUMENT...CWIR: 20 BILLION SHARES OR 31 BILLION SHARES????? Could THIS be the reason for the FINRA long delay? INCREASED from 2 BILLION to 20 BILLION..."On April 18, 2007, the Board of Directors of the Company (the “ Board of Directors ”) and the stockholders of the Company holding a majority of the outstanding shares of common stock of the Company approved an amendment to the Articles of Incorporation to increase the authorized Common Stock from 2,000,000,000 to 20,000,000,000 shares. The text of the Amended and Restated Articles of Incorporation is attached hereto as Appendix A.

HUDSON MAY HAVE BEEN LOOKING AT THE OLD DOCUMENT! The one BEFORE 2007. THIS documents shows 20 BILLION and that 'float' of 600,000,000 HAS TO BE WRONG! No wonder no one could knock that wall down. AND REMEMBER....I have been talking about the 'old preferred'...well, read the document ABOUT SUMMIT!!!!!!

ARTICLE IV - AUTHORIZED SHARES

The total number of shares of stock which the Corporation shall have authority to issue is twenty billion (20,000,000,000) shares of common stock

AND REMEMBER SUMMIT'S 11 BILLION SHARES (Grande said they don't count)...well here they are....

The Board of Directors and the stockholders of the company have approved that certain share exchange, entered into by the Company on April 17, 2007, with Summit Medical Technologies, Inc., a New Hampshire corporation (“Summit”), pursuant to which Summit transferred to the Company 19,500,160 shares of Summit common stock, no par value per share (“Common Stock”), and the Company transferred to Summit 100 shares of the Company’s Series A Preferred Stock, par value $0.01 per share (the “Exchange Agreement”). The Company’s Series A Preferred Stock is convertible into an aggregate of 11,073,757,200 shares of the Company’s common stock, $.001 par value per share, upon the twentieth (20 th ) day after the mailing of a Definitive Schedule 14C Information Statement to the Central shareholders pursuant to the terms and conditions set forth in the Exchange Agreement. The Exchange Agreement contains various representations, warranties, covenants and agreements, and indemnity obligations of the parties.

Summit Medical Technologies is a medical sales and distribution company focusing in the safety and intravenous therapy markets.



http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=5242018

http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=19670&srchyr=2014&SearchStr=cwir

NO WONDER FINRA IS SCRATCHING THEIR HEADS...IS THIS BACK TO THE DRAWING BOARD...OR EXIT STAGE LEFT?????

THIS IS EXACTLY WHY TWEETS DON'T MATTER...right or wrong...no one knows as of right now.